3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
5
Triple Negative Breast Neoplasms
1
Rare Tumour
1
Nasopharyngeal Carcinoma
1
Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer
1
Esophageal Squamour Cell Cancer
1
Advanced Breast Cancer
1
Interventions
Carboplatin
12
pembrolizumab
8
Paclitaxel
8
Cyclophosphamide
8
toripalimab
4
sacituzumab govitecan
4
olaparib
4
Epirubicin
4
Drug Therapy
4
Doxorubicin
4
eribulin
3
Capecitabine
3
130-nm albumin-bound paclitaxel
3
trastuzumab deruxtecan
2
Radiotherapy
2
Injections
2
Gemcitabine
2
taxane
1
poly ICLC
1
pirfenidone
1
palbociclib
1
ivarmacitinib
1
inavolisib
1
fludarabine
1
daratumumab
1
camrelizumab
1
axatilimab
1
anlotinib
1
aldesleukin
1
Vinorelbine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Triple Negative Breast Neoplasms
×
palbociclib
×
Clear all
NCT05067530
2021-10-05
CAREGIVER
Medical University of Gdansk
Phase 2
Not yet recruiting
126 enrolled